Keyword Analysis & Research: harmony biosciences
Keyword Research: People who searched harmony biosciences also searched
Search Results related to harmony biosciences on Search Engine
-
Harmony Biosciences | Patients Are At The Heart Of Everything …
https://www.harmonybiosciences.com/
WEBadvances, we share. our progress. Harmony Biosciences is dedicated to developing & commercializing innovative therapies and novel medications for patients living with rare neurological diseases.
DA: 78 PA: 5 MOZ Rank: 75
-
HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE …
https://ir.harmonybiosciences.com/news-releases/news-release-details/harmony-biosciences-announces-exclusive-agreement-develop-and
WEBApr 11, 2024 · PLYMOUTH MEETING, Pa., April 11, 2024 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced an exclusive licensing agreement with Bioprojet to develop, manufacture and commercialize TPM-1116, a highly potent and selective oral orexin-2 receptor (OX2R) agonist that will be evaluated for the …
DA: 35 PA: 68 MOZ Rank: 11
-
Investor Relations | Harmony Biosciences
https://ir.harmonybiosciences.com/
WEBApr 3, 2024 · Established by founder Paragon Biosciences LLC, our mission is to positively impact the lives of those living with rare diseases who are so often underserved. In August of 2019, Harmony Biosciences received FDA approval for its first commercial product, WAKIX® (pitolisant) tablets.
DA: 72 PA: 13 MOZ Rank: 82
-
Our Products | Harmony Biosciences
https://www.harmonybiosciences.com/our-products/
WEBLearn about Harmony Biosciences' products and get full prescribing information here.
DA: 13 PA: 27 MOZ Rank: 65
-
About | Harmony Biosciences
https://www.harmonybiosciences.com/about-us/
WEBOverview. At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that when empathy and innovation meet, a better life can begin for people living with neurological diseases.
DA: 6 PA: 32 MOZ Rank: 82
-
HARMONY BIOSCIENCES COMPLETES ACQUISITION OF …
https://www.harmonybiosciences.com/newsroom/harmony-biosciences-completes-acquisition-of-zynerba-pharmaceuticals-and
WEBOct 11, 2023 · PLYMOUTH MEETING, PA, October 11, 2023 — Harmony Biosciences Holdings, Inc. (“Harmony”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it has completed its acquisition of Zynerba …
DA: 60 PA: 30 MOZ Rank: 51
-
Science | Harmony Biosciences
https://www.harmonybiosciences.com/science/
WEBHarmony has an exclusive license from Bioprojet to develop, manufacture, and commercialize pitolisant in the United States. ABOUT HBS-102.
DA: 41 PA: 39 MOZ Rank: 15
-
Newsroom | Harmony Biosciences
https://www.harmonybiosciences.com/newsroom/
WEBHARMONY BIOSCIENCES EXPANDS COMMITMENT TO THE RARE NEUROLOGICAL DISEASE COMMUNITY WITH CALL FOR PROGRESS AT THE HEART AND PATIENTS AT THE HEART APPLICATIONS. Feb 22, 2024. Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates. Feb 21, 2024.
DA: 54 PA: 10 MOZ Rank: 28
-
Narcolepsy, Rare Neurological Diseases | Harmony Biosciences
https://www.harmonybiosciences.com/our-focus/
WEBNarcolepsy is a rare, chronic, debilitating neurological disorder of sleep-wake state instability. Narcolepsy impacts approximately 165,000 Americans and is primarily characterized by excessive daytime sleepiness, cataplexy, and other manifestations of REM sleep dysregulation, which intrude into wakefulness.
DA: 67 PA: 64 MOZ Rank: 85
-
Harmony Biosciences Holdings, Inc. (HRMY) - Yahoo Finance
https://finance.yahoo.com/quote/HRMY/
WEBHarmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the...
DA: 31 PA: 10 MOZ Rank: 35
